Who is sponsoring NCT05238805?

NCT05238805 is sponsored by Université de Sherbrooke.

What drugs are being tested in NCT05238805?

Interventions in NCT05238805: Observational heart and kidney on siemens TEP scan.

What condition does NCT05238805 study?

NCT05238805 studies Ketoses, Metabolic.

Is NCT05238805 still recruiting?

NCT05238805 is currently completed. Last updated 18 January 2023.

Last reviewed 2023-01-18 · How we verify

NCT05238805

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Double Pet Project : A Comparison Between 11C-Acetate and 11C-acetoacetate Heart and Kidney Uptake

Completed NA Last updated 18 January 2023

What this trial tests

NA trial testing Observational heart and kidney on siemens TEP scan in Ketoses, Metabolic in 10 participants. Completed in 14 August 2022.

Timeline

14 March 2022

Primary endpoint
14 August 2022

14 August 2022

Quick facts

Lead sponsor	Université de Sherbrooke
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	sequential
Masking	none
Primary purpose	health services research
Enrollment	10
Start date	14 March 2022
Primary completion	14 August 2022
Estimated completion	14 August 2022
Sites	1 location across Canada

Drugs / interventions tested

Observational heart and kidney on siemens TEP scan

Conditions studied

Ketoses, Metabolic — all drugs for Ketoses, Metabolic →

Sponsor

Université de Sherbrooke — full company profile →

Who can join

Adults 18 to 55, any sex, with Ketoses, Metabolic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to make a comparison between 11C-acetate and 11C-Acetoacetate heart and kidney metabolism

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Cardiorenal ketone metabolism: a positron emission tomography study in healthy humans.
Cuenoud B, Croteau E, St-Pierre V, Richard G, et al · · 2023 · cited 4× · PMID 37869718 · DOI 10.3389/fphys.2023.1280191

Verify or expand the search:

Other recruiting trials for Ketoses, Metabolic

Currently open trials in the same condition.

NCT06065657 — Effect of Nutritional Ketosis on Alcohol Metabolism · Phase 2, PHASE3 · active not recruiting

Other Université de Sherbrooke trials

Trials by the same sponsor.

NCT07524764 — Female Reproductive Health in Canadian Armed Forces · not yet recruiting
NCT07511842 — REST-Knee: A Pilot RCT of 72-Hour Knee Immobilization and Pain Outcomes · NA · recruiting
NCT07360587 — Thyroid Artery Embolization for the Treatment of Compressive Goiters. · NA · recruiting
NCT07396857 — The Role of EDHFs on Blood Pressure Following a Bout of Prolonged Sitting · NA · recruiting
NCT07122531 — Recovery With Exogenous Ketones and Antipsychotics · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05238805 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Université de Sherbrooke
Last refreshed: 18 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05238805.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing